Tube filling changeover: cleaning validation or an overnight dry run?
A tube filling line can look ready after an evening format change, yet visual readiness is not the same as validated cleanliness. Product residue may remain beneath nozzles, inside hopper outlets, around tube holders, or in seals that are difficult to inspect during a rushed night shift. The correct decision depends on product risk, equipment design, campaign strategy, and the evidence required for the next batch. Learn more about Gong Ye Jiao Ban 2.
For Australian pharmaceutical, cosmetic, food, and daily chemical manufacturers, the choice is often shaped by TGA expectations, PIC/S GMP principles, production windows, and the practical realities of operating in Sydney, Melbourne, Brisbane, or regional sites. A dry run can confirm mechanical setup and line clearance, but it cannot replace cleaning validation where residue carryover could affect product quality or patient safety.
A sound changeover system separates these activities. Cleaning validation demonstrates that an approved cleaning process removes defined residues to acceptable limits. An overnight dry run confirms that the cleaned and rebuilt tube filler can operate correctly before materials are introduced. They support each other, but they answer different questions.
| Activity | Primary purpose | Typical evidence | What it cannot prove |
|---|---|---|---|
| Cleaning validation | Demonstrate removal of product and microbial residues | Swab or rinse results, recovery studies, approved protocols, worst-case rationale | That the line will run mechanically without faults |
| Routine cleaning verification | Confirm each changeover follows the validated state | Visual inspection, records, targeted tests, operator sign-off | That every future product combination has been validated |
| Overnight dry run | Check format setup and machine function without product | Trial cycles, speed checks, alarms, tube tracking, reject checks | That equipment surfaces are chemically or microbiologically clean |
| Line clearance | Prevent mix-ups and remove previous materials | Area inspection, component reconciliation, clearance checklist | Residue removal beyond the inspection method |
What a validated cleaning process establishes
Cleaning validation is a documented demonstration that a defined method consistently controls carryover. The method normally specifies detergent concentration, water quality, temperature, contact time, mechanical action, rinse stages, drying conditions, and inspection points. It also identifies which surfaces are product-contact surfaces and which areas may influence contamination risk.
For a tube filler, the scope may include the product hopper, dosing pump, filling nozzle, tube gripping parts, sealing jaws, transfer starwheel, guide rails, and any return or recirculation path. Product can collect in dead legs, threaded connections, gasket grooves, and nozzle tips. A simple wipe-down followed by a successful machine cycle does not establish that these locations are clean.
The validation package should include a scientific rationale for sampling locations and analytical limits. Swab recovery must be demonstrated for relevant materials, while rinse sampling may be useful for inaccessible pipework or larger internal surfaces. Limits can be based on health-based exposure limits, therapeutic dose, toxicity, batch size, surface area, or other approved criteria. Visual cleanliness remains important, but it is a baseline requirement rather than the entire validation argument.
What an overnight dry run can confirm
A dry run uses empty tubes or approved non-product components to test the machine after cleaning and format change. It can confirm that tube dimensions are correctly selected, the dosing station is aligned, the coding unit is positioned, sealing temperature is stable, and the discharge conveyor handles tubes without tipping or scuffing. It may also reveal incorrect recipe settings before valuable product is loaded.
The trial is especially useful after a late changeover. A night crew can complete mechanical work, while production or quality personnel review the results during the morning shift. For an Australian site working across rotating rosters, this arrangement can reduce pressure at handover and make equipment faults visible before a scheduled batch starts.
However, empty tubes do not simulate every production condition. They do not show whether a previous cream, ointment, gel, or liquid has been removed from the dosing path. They may also behave differently from filled tubes at the sealing station. A dry run can therefore release the line for setup readiness, not for product cleanliness.
When cleaning validation must take priority
Cleaning validation should take priority when the next product has a lower permitted carryover limit, a different allergen profile, a sensitising active ingredient, a strong colour or odour, or a formulation that adheres to stainless steel and elastomers. Special care is needed when moving from a highly potent medicine to a low-dose product, or from a coloured topical preparation to a pale cream where visual detection is unreliable.
A validated approach is also essential when the line is shared between pharmaceutical and cosmetic products, or when a manufacturer supplies regulated products to several markets. Australian companies commonly align quality systems with PIC/S GMP through the Therapeutic Goods Administration. That means the rationale for cleaning, sampling, acceptance criteria, and deviation handling must be defensible during inspection rather than based only on operator experience.
The campaign sequence can reduce the number of full cleanouts, but it does not eliminate the need for validation. A site may schedule similar products together, use a validated dirty hold time, and reserve the most difficult product for the end of a campaign. Those controls should be supported by data, not treated as an informal shortcut.
How product and equipment risk shape the decision
A risk assessment should examine the formulation, the machine, and the changeover direction. Water-based gels may dry into films that are harder to remove than expected. Ointments can remain in pump cavities and seals. Suspensions may settle in low points. Fragranced or coloured products may leave residues that are detectable by odour or sight but still require analytical confirmation.
Equipment geometry is equally important. A tube filler with quick-release product paths, polished contact surfaces, drainable pipework, and accessible nozzles is easier to validate than a machine with concealed cavities. Manufacturers such as Shanghai Huale Industrial Co., Ltd. build machinery for pharmaceutical, food, and daily chemical applications, so buyers should examine cleanability during technical specification rather than waiting until validation begins.
Change parts should be included in the assessment. A new tube diameter may introduce a different guide, chuck, filling nozzle, or sealing jaw. These components can create additional crevices and may require their own cleaning instructions. The risk file should also consider detergent residues, lubricants, compressed air quality, and the possibility that cleaning water remains trapped before the dry run.
A practical sequence for Australian production sites
A controlled changeover begins with batch completion, material reconciliation, and removal of all previous product and packaging. Operators then disassemble the approved parts, clean according to the standard operating procedure, inspect the equipment, and document the result. Where required, quality personnel collect swabs or rinse samples before the machine is rebuilt.
After cleaning verification is accepted, technicians can install the next format parts and perform the dry run. The run should use a controlled checklist covering tube loading, indexing, dosing motion, sealing, coding, rejection, conveyor transfer, emergency stops, and alarm recovery. Results should be recorded in the electronic batch record or equipment log, including any adjustments made during the trial.
This approach suits facilities that need to coordinate production across local public holidays, limited night-shift staffing, or long-distance technical support from interstate suppliers. A Melbourne cosmetics plant, for example, may use an overnight mechanical trial before a high-volume morning campaign, while a regional Queensland pharmaceutical site may schedule sampling around laboratory courier times. The schedule changes, but the evidence requirements do not.
Packaging line integration also matters. If filled tubes move directly into cartoning or case packing, the dry run should verify the handoff and accumulation points. Guidance on cartoning equipment can help teams consider how upstream tube handling affects downstream packaging performance, especially when speed changes alter spacing or reject timing.
Designing the evidence and acceptance criteria
The cleaning validation protocol should define the product or products selected as worst cases and explain why. Relevant factors include solubility, toxicity, potency, stickiness, colour, batch size, minimum therapeutic dose, and ease of removal. The protocol should state the number of consecutive successful runs, sampling locations, analytical methods, recovery corrections, and actions for out-of-limit results.
Visual inspection needs a defined standard. “Clean” should identify lighting conditions, viewing angles, access tools, and the surfaces that must be checked. A torch, mirror, borescope, or removable inspection panel may be justified for difficult areas. If a surface cannot be inspected reliably, the validation strategy should compensate with suitable sampling or equipment redesign.
Dry-run acceptance criteria should be separate. They may include stable machine speed, correct tube orientation, no tube damage, accurate code placement, reliable sealing, correct reject operation, and no unexpected alarms. A successful dry run can support operational readiness, while cleaning results support hygienic and product-quality release. Combining the two into one sign-off can obscure a failure in either area.
Managing hold times, records, and deviations
Dirty hold time describes how long equipment may remain before cleaning, while clean hold time describes how long it may remain clean before use. Both should reflect actual site conditions, including temperature, humidity, product residue, and protection from the environment. An overnight interval may fall within an approved clean hold time, but that fact alone does not make an unvalidated cleaning process acceptable.
Drying is often underestimated. Residual water can dilute the next formulation, support microbial growth, affect vacuum or dosing behaviour, and create corrosion concerns around unsuitable materials. The procedure should specify how equipment is drained, dried, protected, and inspected before assembly. Compressed air used for drying must be appropriately filtered and controlled.
Any failed swab, unusual residue, alarm, damaged component, or repeated setup adjustment should be recorded as a deviation or maintenance event according to the site system. Recleaning may resolve the immediate issue, but repeated failures can indicate poor nozzle design, an unsuitable detergent, worn seals, or an unrealistic changeover sequence. Trend review turns individual incidents into useful process improvement data.
Building a defensible changeover strategy
The strongest strategy treats cleaning validation and overnight dry runs as linked controls with distinct purposes. Validation establishes that the cleaning method works under defined worst-case conditions. Routine verification confirms that each changeover follows that method. The dry run checks format, control, and mechanical performance before product is committed.
A site may permit a short overnight dry run for a low-risk campaign continuation after routine cleaning verification, while requiring full quality review and analytical testing for a high-risk product change. That decision should be documented in a matrix approved by quality, production, engineering, and validation personnel. Operators should know exactly when a visual check is sufficient, when swabbing is mandatory, and when the equipment must remain locked out.
This discipline is valuable across the wider packaging operation. Film selection, sealing conditions, tube dimensions, cartoning speed, and case-packing interfaces can all affect the final result. For blister operations running alongside tube products, information on blister film choices illustrates the same principle: material and process decisions must be tied to product risk and validated performance.
An overnight dry run is therefore a useful operational safeguard, not a substitute for cleaning validation. When the two controls are clearly separated, Australian manufacturers can shorten avoidable delays while preserving GMP evidence, reliable tube filling performance, and confidence that the next batch starts on a genuinely controlled line.